HOLLIS EDEN PHARMACEUTICALS INC /DE/·4

Jan 7, 1:55 PM ET

BAGLEY PAUL 4

4 · HOLLIS EDEN PHARMACEUTICALS INC /DE/ · Filed Jan 7, 2004

Insider Transaction Report

Form 4
Period: 2003-12-22
BAGLEY PAUL
Director
Transactions
  • Purchase

    Common Stock

    2003-12-22$10.17/sh+2,200$22,37462,380 total
Holdings
  • Common Stock

    (indirect: See Footnote 2)
    500
  • Common Stock

    (indirect: See Footnote 2)
    834
  • Common Stock

    (indirect: By IRA)
    100
Footnotes (3)
  • [F1]Stone Pine Funding Systems, LLC ("SP Funding") owns 500 shares of the Company's Common Stock (the "SP Funding Common Stock"). The reporting person is a member of the Board of Managers of SP Funding and thus shares the right to vote and dispose, or direct the disposition of, the SP Funding Common Stock. As a result, the reporting person may be deemed to be the beneficial owner of the SP Funding Common Stock. The reporting person had a pecuniary interest in 450 shares of the SP Funding Common Stock as of December 22, 2003.
  • [F2]Through general partner interest in Princeton Partners.
  • [F3]LHIP Management Company L.L.C. ("LHIP Management") directly owns 834 shares of the Company's Common Stock (the "LHIP Management Common Stock"). The reporting person is the manager of LHIP Management. As the manager of LHIP Management, the reporting person has the right to vote and dispose, or direct the disposition of, the LHIP Management Common Stock. As a result, the reporting person may be deemed to be the beneficial owner of the LHIP Management Common Stock. The reporting person had a pecuniary interest in 834 shares of the LHIP Management Common Stock as of December 22, 2003.

Documents

1 file
  • 4
    rrd27747.xmlPrimary